Literature DB >> 19604825

Ganglioside syndrome, a new autoimmune neurologic disorder, experimentally induced with brain gangliosides.

Y Nagai1, T Momoi, M Saito, E Mitsuzawa, S Ohtani.   

Abstract

Rabbits intensively immunized with total bovine brain gangliosides or a certain molecular species of gangliosides, such as GD(1a) and GM(1), respectively, in complete Freud's adjuvant developed a variety of neurologic symptoms and signs which closely resembled experimental allergic encephalomyelitis, i.e., a sluggish righting reflex, muscular weakness, hindleg paralysis (flaccid in the case of GD(1a) and rigid in GM(1)) and body weight loss, frequently followed by death. Histological examinations of GD(1a)-immunized rabbits showed extensive degeneration of the peripheral nerves, including breakdown of myelin and fragmentation of axis cylinders. In central nervous tissues, however, only mild damage was observed in some cases. Similar neurologic symptoms and signs were also induced in guinea pigs. The results suggest that this syndrome might be induced by a cell-mediated autoimmune response to gangliosides.

Entities:  

Year:  1976        PMID: 19604825     DOI: 10.1016/0304-3940(76)90033-1

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  15 in total

Review 1.  Immunogenicity of glycolipids.

Authors:  J Portoukalian
Journal:  Clin Rev Allergy Immunol       Date:  2000-08       Impact factor: 8.667

2.  Relationship of adjuvants and swine influenza vaccine to experimental neuropathy in rabbits.

Authors:  H C Powell; A P Mizisin; C A Wiley; M K Morey; R A Hughes
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

Review 3.  Guillain-Barré syndrome: a century of progress.

Authors:  John A Goodfellow; Hugh J Willison
Journal:  Nat Rev Neurol       Date:  2016-11-18       Impact factor: 42.937

Review 4.  Animal models of autoimmune neuropathy.

Authors:  Betty Soliven
Journal:  ILAR J       Date:  2014

Review 5.  Brain and thymus gangliosides: their molecular diversity and its biological implications and a dynamic annular model for their function in cell surface membranes.

Authors:  Y Nagai; M Iwamori
Journal:  Mol Cell Biochem       Date:  1980-02-08       Impact factor: 3.396

Review 6.  The origin of anti-GM1 antibodies in neuropathies: the "binding site drift" hypothesis.

Authors:  Pablo H H Lopez; Ricardo D Lardone; Fernando J Irazoqui; Mariana Maccioni; Gustavo A Nores
Journal:  Neurochem Res       Date:  2002-08       Impact factor: 3.996

7.  Experimental autoimmune neuropathy with anti-GM1 antibodies and immunoglobulin deposits at the nodes of Ranvier.

Authors:  F P Thomas; W Trojaborg; C Nagy; M Santoro; S A Sadiq; N Latov; A P Hays
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

8.  In vivo CNS demyelination mediated by anti-galactocerebroside antibody.

Authors:  K Ozawa; T Saida; K Saida; H Nishitani; M Kameyama
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

9.  Ganglioside GM1, a molecular target for immunological and toxic attacks: similarity of neuropathological lesions induced by ganglioside-antiserum and cholera toxin.

Authors:  B Schwerer; H Lassmann; K Kitz; H Bernheimer
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

10.  Renal glycosphingolipid metabolism is dysfunctional in lupus nephritis.

Authors:  Tamara K Nowling; Andrew R Mather; Thirumagal Thiyagarajan; María José Hernández-Corbacho; Thomas W Powers; E Ellen Jones; Ashley J Snider; Jim C Oates; Richard R Drake; Leah J Siskind
Journal:  J Am Soc Nephrol       Date:  2014-09-30       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.